The St. Baldrick's Foundation in Monrovia, California, has announced fifty-three grants totaling more than $12.9 million to thirty-six institutions in seventeen states, the District of Columbia, and Canada in support of innovative pediatric cancer research.
Grants were awarded in support of efforts to find more effective and less toxic cures for childhood cancers. Recipients include the University of California San Diego School of Medicine, Yale University School of Medicine, Johns Hopkins University School of Medicine, Dana-Farber/Boston Children's Cancer and Blood Disorders Center, Columbia University Irving Medical Center, Baylor College of Medicine, and Huntsman Cancer Institute at the University of Utah.
Due to the postponement or cancellation of nearly two-thirds of its spring fundraising events, the organization was forced to cut its annual grantmaking for the year. Over the last two decades, St. Baldrick's has awarded more than $300 million in support of promising pediatric cancer research. According to the foundation, one in five children in the United States diagnosed with cancer will not survive.
"Childhood cancer researchers are determined, resilient, and perseverant. Although lab closures have caused research delays during the COVID-19 pandemic, the work is forging ahead on many fronts," said St. Baldrick's board member Susan Cohn, who chairs the board's scientific advisory committee. "Because funding sources have also been severely impacted by the pandemic, St. Baldrick's grants are even more important this year. With the support from St. Baldrick's, researchers are able to continue to make new discoveries and develop better treatment options so children with cancer can live longer and healthier lives."
For more information on the organization's 2020 grants, see the St. Baldrick's Foundation website.